EUVIMEDEUVIMED entdecken
Crossref

Snoring and obstructive sleep apnea syndrome as a factor in decreasing patient longevity

A.А. Korobka, A.N. Edeleva, R.A. Larin

Lechaschi Vrach · 11.03.2026 · (3(29))

DOI: 10.51793/os.2026.29.3.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lechaschi Vrach, erschienen am 11.03.2026. Verfasst von A.А. Korobka und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of obstructive sleep apnea syndrome on the cardiovascular system includes a negative impact on blood pressure, cardiac myocardial remodeling, and the progression of arterial atherosclerosis in patients. All these factors contribute to the earlier development and progression of cardiovascular diseases, including arterial hypertension.

Results

Existing data on the impact of obstructive sleep apnea syndrome in patients with various comorbid conditions allow us to draw several conclusions. Sympathetic nervous system activation in obstructive sleep apnea syndrome significantly constricts blood vessels, increases blood pressure and heart rate, which significantly impacts vascular endothelial dysfunction and contributes to the development of hypertension, cardiac arrhythmias, and heart failure. CPAP (Continuous Positive Airway Pressure) therapy in patients with obstructive sleep apnea syndrome has convincingly demonstrated a life-saving effect based on the elimination of dominant cardiovascular risk factors. It has been determined that the main therapeutic measures currently used in the treatment of hypertension include lifestyle modification, dietary interventions, and the use of antihypertensive medications in various combinations. However, in the presence of concomitant obstructive sleep apnea syndrome in such patients, achieving optimal blood pressure without proper treatment of sleep-disordered breathing is extremely difficult, especially in patients with resistant hypertension. Therefore, treatments for sleep-disordered breathing should complement and be actively used in patients with hypertension and concomitant obstructive sleep apnea syndrome. CPAP therapy is one of the most effective treatments for moderate to severe obstructive sleep apnea syndrome.

Conclusion

In the Russian Federation, there are still few reliable, randomized, large-scale studies identifying patients with snoring and obstructive sleep apnea syndrome, monitoring the progression of the disease, and evaluating the effectiveness of treatment methods. This problem intersects with many specialties, including otolaryngology, internal medicine, cardiology, and neurology, and requires an interdisciplinary approach and further study.

Zitieren

APA

Korobka, A., Edeleva, A., & Larin, R. (2026). Snoring and obstructive sleep apnea syndrome as a factor in decreasing patient longevity. Lechaschi Vrach. https://doi.org/10.51793/os.2026.29.3.004

Vancouver

Korobka A, Edeleva A, Larin R. Snoring and obstructive sleep apnea syndrome as a factor in decreasing patient longevity. Lechaschi Vrach. 2026. doi:10.51793/os.2026.29.3.004

BibTeX
@article{Korobka2026,
  author = {Korobka, A.А. and Edeleva, A.N. and Larin, R.A.},
  title = {Snoring and obstructive sleep apnea syndrome as a factor in decreasing patient longevity},
  journal = {Lechaschi Vrach},
  year = {2026},
  number = {3(29)},
  doi = {10.51793/os.2026.29.3.004}
}
Kostenlos starten →